- Home
- REE vs ACHV Comparison
REE vs ACHV Comparison
Compare REE & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REE | ACHV |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 167.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REE | ACHV |
|---|---|---|
| Price | $0.78 | $4.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.75 | ★ $15.50 |
| AVG Volume (30 Days) | 116.6K | ★ 590.2K |
| Earning Date | 12-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $183,000.00 | N/A |
| Revenue This Year | $327.73 | N/A |
| Revenue Next Year | $36,888.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $1.84 |
| 52 Week High | $11.63 | $5.78 |
Technical Indicators
Market Signals| Indicator | REE | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 52.73 |
| Support Level | $0.72 | $4.57 |
| Resistance Level | $0.81 | $4.97 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 30.95 | 57.31 |
Price Performance
Historical ComparisonAbout REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.